Effect of favipiravir and an anti-inflammatory strategy for COVID-19
Hitoshi Yamamura, Hiroshi Matsuura, Junichiro Nakagawa, Hiroshi Fukuoka, Hisaya Domi, Satoru Chujoh
Topics & Concepts
MedicineFavipiravirCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicVirologyCoronavirus InfectionsBetacoronavirusIntensive care medicineOutbreakInternal medicineInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchInflammasome and immune disorders